Neuland Laboratories has informed that the Board of Directors of the Company at its meeting held on October 29, 2014, allotted 12,22,472 fully-paid up Equity Shares of Face Value of Rs. 10 each, out of the Rights Issue of 12,25,276 Equity shares and the balance has been kept in abeyance.
The above information is a part of company’s filings submitted to BSE